Pharma Journalist -

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announces an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing…
Read More...

Vertex Pharmaceuticals announced that the European Commission has granted approval for the label extension of ORKAMBI (lumacaftor/ivacaftor) for the treatment of children with cystic…
Read More...

F-star Therapeutics, an invoX company, announced that it has entered into a strategic discovery collaboration and licence agreement with Takeda. The collaboration will leverage F-star’s…
Read More...

Baudax Bio, Inc. announced the acquisition of TeraImmune, a privately held a biotechnology company focused on discovery and development of novel Treg-based cell therapies for autoimmune…
Read More...

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, and its wholly-owned commercialization subsidiary Tonix Medicines, Inc. (Tonix Medicines), announced it has completed…
Read More...

Eli Lilly and Company and Sigilon Therapeutics, Inc. announced a definitive agreement for Lilly to acquire Sigilon, a biopharmaceutical company that seeks to develop functional cures…
Read More...

Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with platinum-based chemotherapy for the neoadjuvant treatment of…
Read More...

Sangamo Therapeutics, Inc., a genomic medicine company, and Voyager Therapeutics, Inc. announced the parties have entered into a definitive license agreement for a potential treatment…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for…
Read More...

GSK plc and BELLUS Health Inc. announced GSK has completed the acquisition of BELLUS, a biopharmaceutical company working to better the lives of patients suffering from refractory…
Read More...